Skip to main content
Clinical Trials/NCT04147897
NCT04147897CompletedNot Applicable

Implementing mHealth for Schizophrenia in Community Mental Health Settings

University of Washington16 sites in 1 country299 target enrollmentStarted: June 16, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
299
Locations
16
Primary Endpoint
Green Paranoid Thoughts Scale- Part B

Study Overview

Brief Summary

Randomized control trial examining two mHealth intervention strategies.

Detailed Description

The investigators will conduct a multi-site site hybrid type III effectiveness/implementation study in Washington State. The study involves a systematic head-to-head comparison between External Facilitation (EF) and Internal Facilitation (IF) implementation models applied to the FOCUS mHealth intervention.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Green Paranoid Thoughts Scale- Part B

Time Frame: 0,3,6 months

The Green Paranoid Thoughts Scale (GPTS)- part B measures ideas of persecution. Scores range from 16-80. Higher scores represent more severe symptoms.

Patient Health Questionnaire (PHQ)-9

Time Frame: 0,3,6 months

The Patient Health Questionnaire (PHQ)-9 is the major depressive disorder (MDD) module of the full PHQ. Total scores range from 0-27. Higher scores represent more severe symptoms.

Generalized Anxiety Disorder-7 (GAD-7)

Time Frame: 0,3,6 months

The Generalized Anxiety Disorder-7 (GAD-7) measures generalized anxiety disorder symptoms. GAD-7 total score ranges from 0 to 21. Higher scores represent more severe symptoms.

Insomnia Severity Index (ISI)

Time Frame: 0,3,6 months

The Insomnia Severity Index (ISI) is a brief screening assessment tool designed to evaluate insomnia. Total scores range from 0-28. Higher scores represent more severe symptoms.

Hamilton Program for Schizophrenia Voices Questionnaire (HPSVQ)

Time Frame: 0,3,6 Months

A 9-item measure specifically designed to quantify characteristics of auditory hallucinations including frequency, negative content, loudness, duration, interference with life, distress, impact on self-appraisal, and compliance with commands. Total score is a sum of all 9 items. Total HPSVQ scores range from 0-36. Higher scores mean more severe symptoms.

Symptom Check List (SCL-9)

Time Frame: 0,3,6 months

The Symptom Check List-9 (SCL-9) is a brief version of the SCL-90, which aims to evaluate a broad range of psychological problems and symptoms of psychopathology. Total scores are calculated as sum of all responses. Total sum scores range from 0-36. Higher scores mean more severe symptoms.

Illness Management and Recovery Scales (IMRS)

Time Frame: 0,3,6 months

The Illness Management and Recovery Scales (IMRS) measure illness management and recovery. Scoring is a sum of all responses ranging from 15-75. Higher scores mean less severe symptoms.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dror Ben-Zeev

Professor, School of Medicine: Psychiatry And Behavioral Sciences

University of Washington

Study Sites (16)

Loading locations...

Similar Trials